Literature DB >> 5340622

Dipyridamole in the treatment of angina pectoris. A double-blind evaluation.

S Sbar, R C Schlant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5340622

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

Review 1.  North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group.

Authors:  M Eccles; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-04-25

Review 2.  Do we still need dipyridamole?

Authors:  C R Gibbs; G Y Lip
Journal:  Br J Clin Pharmacol       Date:  1998-04       Impact factor: 4.335

3.  Controlled trial of dipyridamole in cerebral vascular disease.

Authors:  J Acheson; G Danta; E C Hutchinson
Journal:  Br Med J       Date:  1969-03-08

4.  Antiplatelet agents in coronary disease: are they of prophylactic value?

Authors:  M Verstraete
Journal:  Drugs       Date:  1978-06       Impact factor: 9.546

5.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

6.  Dipyridamole: a controlled trial of its effect in acute myocardial infarction.

Authors:  A E Gent; C G Brook; T H Foley; T N Miller
Journal:  Br Med J       Date:  1968-11-09

Review 7.  Antiplatelet drugs: clinical pharmacology and therapeutic use.

Authors:  A S Gallus
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546

8.  A comparison of the effects of a series of anti-anginal agents in a novel canine model of transient myocardial ischaemia.

Authors:  M C Allely; B J Alps
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.